However, similar efforts are ongoing in Malawi, which has already proven to be a robust platform for providing cancer care to its patients and for research.19 Currently our laboratory performs oestrogen, progesterone and HER2 staining for breast cancer treatment following guidelines,20,21 differentiation of lymphomas using a basic panel of antibodies,22,23 research-based diagnostics for Kaposi’s sarcoma (KS) using latency-associated nuclear antigen (LANA-1) and Wilm’s tumour. Here, ERBB2 is linked to breast carcinoma.